ECRAF(ECRAF)
ECRAF
No analyst ratings available
No analyst price targets available for ECRAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $76M | $73M | $76M | $79M | $116M |
| Low | $70M | $66M | $69M | $72M | $106M |
| High | $81M | $83M | $83M | $87M | $128M |
| EBITDA Avg | $73M | $73M | $79M | $90M | $136M |
| Low | $68M | $68M | $74M | $84M | $126M |
| High | $79M | $78M | $85M | $97M | $148M |
| EBIT Avg | $54M | $50M | $53M | $62M | $101M |
| Low | $49M | $45M | $48M | $56M | $91M |
| High | $60M | $55M | $59M | $68M | $113M |
| Net Income Avg | $36M | $33M | $36M | $42M | $74M |
| Low | $32M | $29M | $32M | $37M | $65M |
| High | $41M | $37M | $40M | $48M | $83M |
| EPS Avg | $0.14 | $0.13 | $0.14 | $0.17 | $0.29 |
| Low | $0.13 | $0.12 | $0.13 | $0.15 | $0.26 |
| High | $0.16 | $0.15 | $0.16 | $0.19 | $0.33 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 | 3 / 1 | 5 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $16M |
| Low | $16M |
| High | $16M |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |